M. Hatori, Yoshihiro Totuka, H. Yamanaka
Dec 1, 2001
Citations
0
Influential Citations
4
Citations
Journal
International Journal of Urology
Abstract
Abstract Background: Fosfestrol drip infusion therapy is an available endocrinotherapy for prostate cancer. But since there have been few reports of its use in chronic dialysis patients, the pharmacokinetics of fosfestrol in these patients remains unclear. We conducted fosfestrol drip infusion therapy as an induction therapy in chronic hemodialysis patients with prostate cancer.